GW433908
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GW433908, covering 2012-06-21 to 2013-05-14. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination [Phase 4]